Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3699880012 | Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3699881011 | Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 15 milligram and reserpine 100 microgram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Is a | Product containing hydrochlorothiazide (medicinal product) | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Is a | Product containing hydralazine (medicinal product) | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has active ingredient | Hydralazine (substance) | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has active ingredient | Hydrochlorothiazide (substance) | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Is a | Product containing hydralazine hydrochloride and hydrochlorothiazide and reserpine | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has active ingredient | Hydralazine hydrochloride | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has active ingredient | Centrally acting hypotensive agent (substance) | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has active ingredient | Reserpine (substance) | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Is a | Hydralazine-containing product in oral dose form | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Is a | Hydrochlorothiazide-containing product in oral dose form | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has active ingredient | Reserpine (substance) | false | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has basis of strength substance (attribute) | Reserpine (substance) | true | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator value | 0.1 | false | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 3 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 3 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has active ingredient | Hydralazine hydrochloride | false | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has basis of strength substance (attribute) | Hydralazine hydrochloride | true | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator value | 25 | false | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has basis of strength substance (attribute) | Reserpine (substance) | false | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has basis of strength substance (attribute) | Hydralazine hydrochloride | false | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator value | 25 | false | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has active ingredient | Hydrochlorothiazide (substance) | false | Inferred relationship | Some | 3 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has basis of strength substance (attribute) | Hydrochlorothiazide (substance) | true | Inferred relationship | Some | 3 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator value | 15 | false | Inferred relationship | Some | 3 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Is a | Product containing hydrochlorothiazide and reserpine (medicinal product) | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has precise active ingredient | Hydralazine hydrochloride | false | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Is a | Product containing rauwolfia alkaloid in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has precise active ingredient | Hydrochlorothiazide (substance) | true | Inferred relationship | Some | 3 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has precise active ingredient | Reserpine (substance) | false | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Is a | Hydralazine- and hydrochlorothiazide-containing product in oral dose form | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Count of base of active ingredient | 3 | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator value | 100 | false | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator unit | mcg | false | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Is a | Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form | true | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Plays role | Diuretic therapeutic role | true | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has precise active ingredient | Hydralazine hydrochloride | true | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has precise active ingredient | Reserpine (substance) | true | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets